* Sabra Health Care REIT Inc SBRA.OQ SBRA.O is expected to
show a rise in quarterly revenue when it reports results on May
5.
* The Irvine, California-based company is expected to report a
0.5% increase in revenue to $150.128 million from $149.35
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Sabra Health Care REIT
Inc is for earnings of 17 cents per share. For the same quarter
last year, the company reported earnings of 17 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 5 "strong buy" or "buy," 8
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by about 0.5%
in the last three months.
* Wall Street's median 12-month price target for Sabra Health
Care REIT Inc is $18.5, about 1.8% above its last closing
price of $18.17.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 0.44 0.43 0.42 Missed -2.9
Sep. 30 2020 0.42 0.42 0.48 Beat 14.1
Jun. 30 2020 0.39 0.40 0.45 Beat 13.5
Mar. 31 2020 0.44 0.44 0.45 Beat 2.8
Dec. 0.45 0.45 0.48 Beat 6
31 2019
Sep. 30 2019 0.46 0.46 0.47 Beat 1.6
Jun. 30 2019 0.48 0.48 0.46 Missed -3.2
Mar. 31 2019 0.47 0.49 0.48 Missed -1.3
This summary was machine generated May 3 at 21:05 GMT. All
figures in US dollars unless otherwise stated